Published on Monday June 06, 2022
We are working on the following new projects:
- Smooth signed a contract for a bioequivalence trial with Rivaroxaban.
- We signed two contracts for medical writing services and two other contracts for publications preparation with different clients.
We are happy to reach the following milestones in our projects:
- The enrollment starts in all sites in the trial with Nimesulide 2% gel.
- The CSR in the Azacitidine trial was finalized.
- The CTAs were received in the Sildenafil and Rivaroxaban studies.